Učitavanje...
Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
INTRODUCTION: AKR1C3 is a drug target in hormonal and hormonal independent malignancies and acts as a major peripheral 17β-hydroxysteroid dehydrogenase to yield the potent androgens testosterone and dihydrotestosterone, and as a prostaglandin (PG) F synthase to produce proliferative ligands for the...
Spremljeno u:
| Izdano u: | Expert Opin Ther Pat |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5724044/ https://ncbi.nlm.nih.gov/pubmed/28895472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2017.1379503 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|